Ford G A, Hoffman B B, Blaschke T F
Division of Clinical Pharmacology, Stanford University School of Medicine, California.
J Gerontol. 1992 Jan;47(1):M22-6. doi: 10.1093/geronj/47.1.m22.
Aging is associated with diminished beta-adrenergic responsiveness in a variety of tissues. Desensitization of tissues secondary to the age-associated increase in sympathetic nervous system activity has been proposed as a potential explanation for diminished beta-adrenergic responsiveness. If this hypothesis is correct, then beta-blockade in older people might be expected to reverse the blunted beta-adrenergic responses of tissues having diminished responsiveness. Cardiac chronotropic responses to bolus isoproterenol (ISO) doses and ISO-induced venous smooth muscle dilatation in superficial hand veins were examined in 8 young (26.2 +/- 2.6 yrs) and 9 elderly (68.0 +/- 2.2 yrs) healthy subjects before, during, and 3 and 7 days following 2 weeks of treatment with propranolol. Baseline cardiac chronotropic responsiveness, CD25, was 1.55 +/- 0.77 mcg in the young and 5.97 +/- 2.77 mcg in the elderly subjects (p less than .01), increasing to 84 +/- 56 mcg and 194 +/- 172 mcg during treatment with propranolol. At 3 and 7 days following withdrawal of propranolol, CD25s were respectively 1.24 +/- 0.79 (p = .14) and 1.10 +/- 0.42 (p = .04) in the young and 5.63 +/- 2.34 (p = .31) and 4.85 +/- 2.37 (p = .05) in the elderly subjects. In contrast, there was no decrease in the ED50 or increase in Emax for ISO-induced venodilation of hand veins following propranolol withdrawal. These results demonstrate that both young and elderly subjects have similar increases in cardiac chronotropic responsiveness following discontinuation of beta-blockade and do not support the concept that desensitization is responsible for the diminished beta-adrenergic responsiveness seen with aging.
衰老与多种组织中β-肾上腺素能反应性降低有关。有人提出,由于交感神经系统活动随年龄增长而增加导致组织脱敏,这可能是β-肾上腺素能反应性降低的一个潜在解释。如果这一假设正确,那么预计对老年人进行β受体阻滞剂治疗可能会逆转反应性降低的组织中钝化的β-肾上腺素能反应。在8名年轻(26.2±2.6岁)和9名老年(68.0±2.2岁)健康受试者中,在使用普萘洛尔治疗2周之前、期间以及停药后3天和7天,检测了静脉推注异丙肾上腺素(ISO)剂量后的心脏变时反应以及ISO诱导的手部浅表静脉平滑肌扩张。年轻受试者的基线心脏变时反应性CD25为1.55±0.77微克,老年受试者为5.97±2.77微克(p<0.01),在使用普萘洛尔治疗期间分别增加到84±56微克和194±172微克。在停用普萘洛尔后3天和7天,年轻受试者的CD25分别为1.24±0.79(p = 0.14)和1.10±0.42(p = 0.04),老年受试者分别为5.63±2.34(p = 0.31)和4.85±2.37(p = 0.05)。相比之下,停用普萘洛尔后,手部静脉ISO诱导的静脉扩张的半数有效剂量(ED50)没有降低,最大效应(Emax)也没有增加。这些结果表明,停用β受体阻滞剂后,年轻和老年受试者的心脏变时反应性均有类似增加,不支持脱敏是衰老过程中β-肾上腺素能反应性降低原因的观点。